EMCDDA Home
  • EN
Search

publication thumbnail Conference proceedings: Identifying Europe's information needs for effective drug policy
Download the conference proceedings from our Publications database.

Photos

Highlights

Aníbal Cavaco Silva
Aníbal Cavaco Silva, President of the Portuguese Republic

José Sócrates
José Sócrates, Prime Minister of Portugal

Marcel ReimanMarcel Reimen, Chairman EMCDDA Management Board

Wolfgang Götz
Wolfgang Götz, EMCDDA Director

Michael Farrell
Michael Farrell, Chairman, EMCDDA Scientific Committee

Georges Estievenart
Georges Estievenart, Honorary EMCDDA Director

Day 1 (6th May)

Michels
Ingo Michels

Rehm
Jürgen Rehm

Jablonski
Piotr Jabłoński

Edwards
Carel Edwards

Chawla
Sandeep Chawla

Perron
Michel Perron

photo of audience
Audience, opening session

The panel
Panel, opening session

Wolfgang Götz
Wolfgang Götz

Marcel Reimen
Marcel Reimen

Kamil Kalina
Kamil Kalina

Franisco Fonseca Morillo
Francisco Fonseca Morillo

Jose Socrates
José Sócrates

Jose Socrates
José Sócrates

Day 2 (7th May)

Panel plenary session Thursday afternoon
Panel, plenary session Thursday afternoon

Alan Lodwick
Alan Lodwick

Terry Zobeck
Terry Zobeck

Wayne Hall
Wayne Hall

Dirk Korf
Dirk Korf

Panel parallel session A Thursday afternoon
Panel, parallel session A Thursday afternoon

Björn Hibell
Björn Hibell

Jane Mounteney
Jane Mounteney

Tim Pfeiffer-Gerschel
Tim Pfeiffer-Gerschel

Les King
Les King

Panel, parallel session B Thursday afternoon
Panel, parallel session B Thursday afternoon

Mirjam Kretzschmar
Mirjam Kretzschmar

Éva Keller
Éva Keller

François Beck
François Beck

Paul Dargan
Paul Dargan

Panel, parallel session C Thursday afternoon
Panel, parallel session C Thursday afternoon

Jean-Michel Costes
Jean-Michel Costes

Franz Trautmann
Franz Trautmann

Tomáš Zabranský
Tomáš Zabranský

Thomas Pietschmann
Thomas Pietschmann

Victor Mravcik
Victor Mravcik

De-Ruyver
Brice De Ruyver

Edwards
Irmgard Eisenbach-Stangl

Sloboda
Zili Sloboda

Stevens
Alex Stevens

Torrens
Marta Torrens

Tossmann
Peter Tossmann

Turnbull
Paul Turnbull

Verster
Annette Verster

Weilandt
Caren Weilandt

Prego
Joana Prego

Marsden
John Marsden

Krajewski
Krzysztof Krajewski

Haasen
Christian Haasen

picture of Lisbon Congress Centre
Lisbon Congress Centre

Garretsen
Henk Garretsen

Fischer
Gabriele Fischer

Farrell
Michael Farrell

Bergeron
Henri Bergeron

Burkhart
Gregor Burkhart

Calafat
Amador Calafat

Davioli
Marina Davoli

Day 3 (8th May)

Wolfgang Götz
Wolfgang Götz

Mariano Simancas
Mariano Simancas

Carel Edwards
Carel Edwards

Aníbal Cavaco Silva
Aníbal Cavaco Silva

Panel, wrap-up session
Panel, wrap-up session

Ralf Löfstedt
Ralf Löfstedt

Virginia Berridge
Virginia Berridge

Paul Griffiths
Paul Griffiths

Roland Simon
Roland Simon

Michael Farrell
Michael Farrell

Panel, plenary session Friday morning
Panel, plenary session Friday morning

Jean-Pol Tassin
Jean-Pol Tassin

Gerhard Bühringer
Gerhard Bühringer

Paul Cook
Paul Cook

John Ramsey
John Ramsey

conference logo

EMCDDA conference: 6-8 May 2009, Lisbon
Identifying Europe’s information needs for effective drug policy

The EMCDDA has been reporting on the drug situation in Europe since the mid-1990s and, since then, both the drug problem and how Member States respond to it have evolved considerably. During this period, a commitment to evidence-based policymaking has been accompanied by a steady growth in the amount and quality of the information available to facilitate and support the policy debate.

The conference, 'Identifying Europe’s information needs for effective drug policy', highlights four main themes: Policy, Practice, Trends and Horizons. It provides an opportunity for policymakers, researchers and practitioners to:

  • take stock of progress in European drug policy and the EMCDDA’s role in this;
  • identify and consider future key issues for the drug situation in Europe;
  • propose how these issues may impact on information needs.

Programme

Overview of the programme

An overview of the programme for each day can be found below (note that this information, along with more detailled information on each session, is also available in the full programme).

Day 1

Conference day 1 programme extracted in image format from the full programme (available as a PDF)

Day 2

Conference day 2 programme extracted in image format from the full programme (available as a PDF)

Day 3

Conference day 3 programme extracted in image format from the full programme (available as a PDF)

Programme guide (PDF)

The full programme for the conference in PDF format can be downloaded below. Note that there have been small changes to the programme which have not been updated in this PDF but these changes have been incoporated in the Presentations section below.

publication thumbnail

Bio notes for the speakers along with abstracts can be found in the Presentation section below.

top of page

Presentations, abstracts and bio notes

Presentations and posters from the conference, and other related documents will be added here as they become available.

Wednesday 6 May, 16.00–18.30: Plenary thematic session I: Policy
Information needs for policy — implications for monitoring and science

Chair: Ingo Michels, Office of the Drug Commissioner, Germany

1. Making connections — the questions we have to answer

Speaker: Jürgen Rehm, Technical University Dresden, Dresden, Germany

2. The National perspective

Speaker: Piotr Jabłoński, National Bureau for Drug Prevention, Warsaw, Poland and Pompidou Group of the Council of Europe

3. The European perspective

Speaker: Carel Edwards, European Commission, Directorate-General for Justice, Freedom and Security

4. The International perspective

Speaker: Sandeep Chawla, United Nations Office on Drugs and Crime (UNODC)

5. Civil society forum on drug

Speaker: Michel Perron, Canadian Centre on Substance Abuse, Ottawa, Canada

top of page

Thursday 7 May, 9.00–10.30: Plenary thematic session II: Practice
Making the link between science and practice

Chair: Henri Bergeron, Centre of Sociology of Organisations, (CSO), CNRS, Paris, France (bio notes)

1. Making science speak to policy and practice

Speaker: Michael Farrell, Chair of the EMCDDA Scientific Committee of the EMCDDA

2. Understanding the evidence base

Speaker: Marina Davoli, Italian National Health Service, Department of Epidemiology, Rome, Italy

3. Moving beyond experimentation — translating evidence into practice

Speaker: Henk Garretsen, Tilburg University, Tilburg, The Netherlands

4. Doing it well

Speaker: Zili Sloboda, University of Akron, Akron, USA

top of page

Thursday 7 May, 11.00–12.30: Parallel session A
Treatment and harm reduction, needs for more tailored interventions

Chair: Annette Verster, World Health Organization (WHO) (bio notes)

1. Making treatment systems more recovery-oriented

Speaker: John Marsden, National Addiction Center London, UK

2. Heroin prescription — new responses for the hard to treat

Speaker: Christian Haasen, University of Hamburg, Hamburg, Germany

3. Addressing psychosocial needs

Speaker: Marta Torrens, Municipal Institute of Medical Investigation (IMIM), Hospital del Mar, Barcelona, Spain

4. Meeting different needs — treatment targeted at specific groups

Speaker: Gabriele Fischer, Medical University, Vienna, Austria

Thursday 7 May, 11.00–12.30: Parallel session B
From prevention to treatment — finding the right group

Chair:  Irmgard Eisenbach-Stangl, European Centre for Social Welfare Policy and Research (bio notes)

1. Indicated prevention — targeting those most at risk

Speaker: Gregor Burkhart, EMCDDA, on behalf of Jörg Fegert, Ulm University Hospital, Ulm, Germany

2. Prevention in nightlife settings — intervening early by staying up late

Speaker: Amador Calafat, European Institute of Studies on Prevention (IREFREA), Palma de Mallorca, Spain

3. Targeting mental health — working in and with the families

Speaker: Joana Prego, Gabinete de Atendimento à Família, Viana do Castelo, Portugal

4. Internet-based interventions — messages that click

Speaker: Peter Tossmann, Delphi Society for Research, Berlin, Germany

Thursday 7 May, 11.00–12.30: Parallel session C
Interventions related to criminal justice and drug supply

Chair: Brice De Ruyver, University of Ghent, Belgium (bio notes)

1. Gaps in the knowledge-base — evidence in the criminal justice system and its implementation in practice

Speaker: Krzysztof Krajewski, Jagiellonian University, Cracow, Poland

2.  Treatment and harm reduction in prison and continuity of care

Speaker: Caren Weilandt, Scientific Institute of the German Medical Association (WIAD), Bonn, Germany

3. Alternatives to imprisonment — scope and evidence

Speaker: Alex Stevens, University of Kent, Canterbury, UK

4. Supply reduction — how to define it and how it could be monitored

Speaker: Paul Turnbull, Institute for Criminal Policy, School of Law, King's College London, UK

top of page

Thursday 7 May, 14.00–15.30: Plenary thematic session III: Trends
Monitoring a fast-moving, complex phenomenon

Chair: Franz Pietsch, Federal Ministry of Health and Women, Vienna, Austria (bio notes)

1.  The Reitox experience — lessons learned in developing a network of national focal points and challenges for the future

Speakers: Alan Lodwick, Head of the UK national focal point (NFP) and Reitox Spokesperson and Viktor Mravcik, Head of the Czech Republic NFP

2. What can Europe learn from the US experience of policy-related drugs monitoring?

Speaker: Terry Zobeck, The White House Office of National Drug Control Policy (ONDCP), Washington D.C., USA

3. What can Europe learn from the Australian experience of policy-related drugs monitoring?

Speaker: Wayne Hall, University of Queensland, Brisbane, Australia

4. The missing link — how do we include qualitative information in monitoring systems?

Speaker: Dirk Korf, University of Amsterdam, Amsterdam, The Netherlands

top of page

Thursday 7 May, 16.00–17.30: Parallel session A
Understanding the intricacies of Europe

Chair: Marcel De Kort, Member of the EMCDDA Management Board, The Netherlands

1.  ESPAD — are young Europeans getting more alike?

Speaker: Björn Hibell, Swedish Council for Information on Alcohol and Other Drugs (CAN), Stockholm, Sweden

2. Keeping on target — the need for more rapid and policy-relevant reporting

Speaker: Jane Mounteney, Bergen Clinics, Bergen, Norway

3.  Blurred lines — prescription, over-the-counter and in-the-post medicinal products

Speaker: Tim Pfeiffer-Gerschel, Institute for Therapy Research (IFT), Munich, German

4. New drugs coming our way — what are they and how do we detect them?

Speaker: Les King, former head of the drugs intelligence unit, Forensic Science Service, and member of the Home Office Advisory Council on the Misuse of Drugs (ACMD), Basingstoke, UK

Thursday 7 May, 16.00–17.30: Parallel session B
Drug problems and consequences

Chair: João Goulão, National Drugs Coordinator, Ministry of Health, Portugal

1. HIV and HCV, TB and other drug-related infections — the way forward

Speaker: Mirjam Kretzschmar, Centre for Infectious Disease Control, Bilthoven, The Netherlands

2.  Monitoring drug-related overdose and mortality in Europe

Speaker: Éva Keller, Semmelweis University, Budapest, Hungary

3.  Problem cannabis use — what is it and how to assess it?

Speaker: François Beck, National Institute for Prevention and Health Education, Saint Denis, France

4. Monitoring drug emergencies — what does it tell us?

Speaker: Paul Dargan, National Health Service Foundation Trust (NHS), Guy´s and St Thomas´ Hospital, London, UK

Thursday 7 May, 16.00–17.30: Parallel session C
Trafficking routes and markets

Chair: Robert Hauschild, Europol (bio notes)

1. Mapping the changing European cannabis market place

Speaker: Jean-Michel Costes, French Monitoring Centre for Drugs and Drug Addiction (OFDT), Saint-Denis, France

2.  Impact of drug policy on the drugs market

Speaker: Franz Trautmann, Trimbos Institute, Utrecht, The Netherlands

3.  Amphetamines — trends in stimulant production and use in Europe

Speaker: Tomáš Zabranský, Center of Addictology at the Psychiatric Clinic, 1st Medical Faculty, Charles University, Prague, Czech Republic

4.  What’s happening to heroin? Methodological challenges in understanding trends in heroin production and supply

Speaker: Thomas Pietschmann, United Nations Office on Drugs and Crime (UNODC)

top of page

Friday 8 May, 09.00–10.30: Plenary thematic session IV: Horizons
Arising issues

Chair: Fernando Rodriguez de Fonseca, Fundación Imabis, Hospital University Carlos Haya, Malaga, Spain (bio notes)

1. Drug use and addiction — new scientific findings

Speaker: Jean-Pol Tassin, Collège de France, Paris, France

2. Emerging research needs

Speaker: Gerhard Bühringer, Institute for Therapy Research (IFT), Munich, and Technical University of Dresden, Dresden, Germany

3.  Looking out from the EMCDDA — regional systems in a global perspective

Speaker: Paul Cook, International consultant on drugs and drug addiction, Manchester, UK

4. Monitoring in the technological age

Speaker: John Ramsey, St George´s Hospital Medical School, London, UK

Friday 8 May, 11.00–12.00: Wrap-up session
Taking forward the findings

Chair: Ralf Löfstedt, Swedish Ministry of Health and Social Affairs, Stockholm, Sweden (bio notes)

1. Learning from the past to plan for the future

Speaker: Virginia Berridge, London School of Hygiene and Tropical Medicine, UK

2. Wrap-up presentation: What has the EMCDDA learnt?

Speakers: Paul Griffiths and Roland Simon, EMCDDA

3. Raising the bar — meeting Europe´s future challenges

Speaker: Michael Farrell, Chair of the EMCDDA Scientific Committee, National Addiction Centre, Kings College London, UK

Information for participants

Roadbook: an A to Z of general information on the conference and Lisbon

The Roadbook provides practical information on Lisbon and the conference.

publication thumbnail

EMCDDA overview brochure

publication thumbnail

Participants list

publication thumbnail

Hotel information

List of hotels with negotiated prices for the EMCDDA Conference.

Note, if you are booking with the Hotel Vila Galé Ópera or in one of the Tivoli forms use the appropriate form below:

Registration information

Our online registration has now closed. If you have an invitation and still wish to attend the event, registration is possible at the conference venue from noon on 6 May.

Registered participants: manage your registration.

Lisbon tourist information

The Lisbon tourism site provides tourist information on Lisbon in six languages.

Lisbon weather (Accuweather service)

Information on the weather in Lisbon can be found here.

top of page

Press information

News releases

EMCDDA conference highlights (8.5.2009)

EMCDDA to celebrate 15 years of drug monitoring with international conference (28.4.2009)

Additional news releases will be added here once available.

Press enquiries

For press enquiries during the conference, please contact (+351) 96 324 0834.

Presentations and speeches

Presentations and speeches can be found in the Presentations section above.

top of page

Photos

Full resolution photos can be found in the righthand sidebar of this page. They will be added as they become available.

top of page

 

 

 

 

 

Page last updated: Tuesday, 09 August 2011